Clinical Trials in Philadelphia

Showing 8641-8660 of 20,904 trials

Human Epilepsy Project 2: Resistant Focal Seizures Study

NCT03531008

The HEP2 study is designed to better understand the challenges of living with focal seizures that do not respond to medication, by following 205 people with medication-resistant focal epilepsy over two years to measure changes in health status, healthcare costs, quality of life, and biomarkers of epilepsy severity and treatment response.

EpilepsyBrain DiseasesCentral Nervous System Diseases+2 more

Epilepsy Foundation of America157 participantsStarted May 2018

San Francisco, California, United States • New Haven, Connecticut, United States • Miami, Florida, United States +7 more locations

COMPLETEDPhase 2< 1 mile

Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome

NCT03905525

This study will evaluate safety, efficacy, pharmacokinetics (PK) and pharmacodynamics (PD) of multiple doses of CFZ533 (iscalimab) in patients with Sjögren's Syndrome.

Sjögren Syndrome

Novartis Pharmaceuticals273 participantsStarted Oct 2019

Duluth, Georgia, United States • Indianapolis, Indiana, United States • Baton Rouge, Louisiana, United States +68 more locations

Human Epilepsy Project 2: Resistant Focal Seizures Study

Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome

Find Trials by Condition in Philadelphia

Cranial Blocks for Postoperative Anesthesia

Testing Informed Decision Making in Lung Cancer Screening

Understanding the Effects of Quantitatively-Prescribing Passive-Dynamic Ankle-Foot Orthosis Bending Stiffness for Individuals Post-Stroke

Addressing Dementia Via Agitation-Centered Evaluation

Caffeine in the Second Stage of Labor in Low-risk Nulliparous Mothers at Term

Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer

Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation

A Study of BTX-1188 in Subjects With Advanced Malignancies

Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia

INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy

Multi-Center Pilot Study of Cutera truSculpt Device

Clinical Use Cases Assessment of the Gabi System in Young Children With Underlying Medical Conditions (BRIDGE Study)

Study of a Novel Laser for Skin Rejuvenation

Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants

A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor

Pilot Study of Multi-wavelength Laser for Tattoo Removal